ClinicalTrials.Veeva

Menu

Point of Care Evaluation of Fibrinolysis in Sepsis (POCEFIS)

P

Policlinico Hospital

Status

Enrolling

Conditions

Fibrinolytic Defect
Critical Illness
Sepsis

Treatments

Diagnostic Test: Clot Pro

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Impaired fibrinolysis in septic patients is associated with worse outcome. The present study investigates fibrinolysis shutdown in septic patients, defined as prolonged ClotPro® TPA lysis time at 30 minutes. The TPA lysis time reference range is established in a cohort of healthy volunteers.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age > 18 years
  • sepsis or septic shock
  • vasopressors required to maintain a MAP ≥ 65 mmHg despite adequate fluid resuscitation

Exclusion criteria

  • coagulation disorders
  • ECMO therapy
  • use of oral anticoagulant drugs

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Septic patients
Other group
Treatment:
Diagnostic Test: Clot Pro
Healthy volunteers
Other group
Treatment:
Diagnostic Test: Clot Pro

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems